Buyer Name: CARDIFF UNIVERSITY
Buyer Address: Park Place, Cardiff, UKL22, CF10 3AT, United Kingdom
Contact Name: Jamie Jones
Contact Email: procurement@cardiff.ac.uk
Buyer Name: CARDIFF UNIVERSITY
Buyer Address: Park Place, Cardiff, UKL22, CF10 3AT, United Kingdom
Contact Name: Jamie Jones
Contact Email: procurement@cardiff.ac.uk
Cardiff University's School of Medicine is procuring the manufacture of a novel investigational medicinal product (IMP), Triiodothyronine sulphate (T3S), for use in a Phase 2b clinical trial. The service includes the production of the active pharmaceutical ingredient (API), the IMP, and the finished drug formulation (FDF) in blister packs. This bespoke drug is intended for hypothyroid patients with a specific genetic variation affecting thyroid hormone metabolism. The supplier will manufacture the product to GMP standards, using a validated Route of Synthesis supported by existing preclinical and toxicology data.
No linked documents found for this notice.
Lot 1 Status: complete
Award Title: LIONNS-D2 Project - Production of T3S API, IMP and FDF
{
"awards": [
{
"aboveThreshold": true,
"contractPeriod": {
"endDate": "2027-01-31T23:59:59Z",
"startDate": "2025-11-06T00:00:00Z"
},
"date": "2025-10-22T00:00:00+01:00",
"documents": [
{
"datePublished": "2025-10-24T09:23:16+01:00",
"description": "Contract award notice on Find a Tender",
"documentType": "awardNotice",
"format": "text/html",
"id": "068032-2025",
"noticeType": "UK6",
"url": "https://www.find-tender.service.gov.uk/Notice/068032-2025"
}
],
"id": "1",
"items": [
{
"additionalClassifications": [
{
"description": "Pharmaceutical products",
"id": "33600000",
"scheme": "CPV"
}
],
"deliveryAddresses": [
{
"country": "GB",
"countryName": "United Kingdom",
"region": "UKL"
}
],
"id": "1",
"relatedLot": "1"
}
],
"mainProcurementCategory": "goods",
"milestones": [
{
"dueDate": "2025-11-05T23:59:59Z",
"id": "1",
"status": "scheduled",
"type": "futureSignatureDate"
}
],
"relatedLots": [
"1"
],
"standstillPeriod": {
"endDate": "2025-11-04T23:59:59+00:00"
},
"status": "pending",
"suppliers": [
{
"id": "GB-PPON-PRMH-6467-WRPY",
"name": "Ardena Holding NV"
}
],
"title": "LIONNS-D2 Project - Production of T3S API, IMP and FDF",
"value": {
"amount": 953600.0,
"amountGross": 953600.0,
"currency": "EUR"
}
}
],
"buyer": {
"id": "GB-COH-RC000089",
"name": "CARDIFF UNIVERSITY"
},
"date": "2025-10-24T09:23:16+01:00",
"id": "068032-2025",
"initiationType": "tender",
"language": "en",
"ocid": "ocds-h6vhtk-05d2df",
"parties": [
{
"additionalIdentifiers": [
{
"id": "PHVT-4343-HWYR",
"scheme": "GB-PPON"
}
],
"address": {
"country": "GB",
"countryName": "United Kingdom",
"locality": "Cardiff",
"postalCode": "CF10 3AT",
"region": "UKL22",
"streetAddress": "Park Place"
},
"contactPoint": {
"email": "procurement@cardiff.ac.uk",
"name": "Jamie Jones"
},
"details": {
"classifications": [
{
"description": "Public authority - sub-central government",
"id": "publicAuthoritySubCentralGovernment",
"scheme": "UK_CA_TYPE"
},
{
"description": "Welsh devolved regulations apply",
"id": "GB-WLS",
"scheme": "UK_CA_DEVOLVED_REGULATIONS"
}
],
"url": "http://www.cardiff.ac.uk"
},
"id": "GB-COH-RC000089",
"identifier": {
"id": "RC000089",
"scheme": "GB-COH"
},
"name": "CARDIFF UNIVERSITY",
"roles": [
"buyer"
]
},
{
"address": {
"country": "BE",
"countryName": "Belgium",
"locality": "Mariakerke",
"postalCode": "9030",
"region": "BE",
"streetAddress": "Kleimoer 4"
},
"contactPoint": {
"email": "info@ardena.com"
},
"details": {
"publicServiceMissionOrganization": false,
"scale": "large",
"shelteredWorkshop": false,
"url": "http://www.ardena.com",
"vcse": false
},
"id": "GB-PPON-PRMH-6467-WRPY",
"identifier": {
"id": "PRMH-6467-WRPY",
"scheme": "GB-PPON"
},
"name": "Ardena Holding NV",
"roles": [
"supplier"
]
}
],
"tag": [
"award",
"contract"
],
"tender": {
"description": "Cardiff University\u0027s School of Medicine is procuring the manufacture of a novel investigational medicinal product (IMP), Triiodothyronine sulphate (T3S), for use in a Phase 2b clinical trial. The service includes the production of the active pharmaceutical ingredient (API), the IMP, and the finished drug formulation (FDF) in blister packs. This bespoke drug is intended for hypothyroid patients with a specific genetic variation affecting thyroid hormone metabolism. The supplier will manufacture the product to GMP standards, using a validated Route of Synthesis supported by existing preclinical and toxicology data.",
"id": "CU.1623.RR",
"legalBasis": {
"id": "2023/54",
"scheme": "UKPGA",
"uri": "https://www.legislation.gov.uk/ukpga/2023/54/contents"
},
"lots": [
{
"id": "1",
"status": "complete"
}
],
"procurementMethod": "direct",
"procurementMethodDetails": "Direct award",
"status": "complete",
"title": "LIONNS-D2 Project - Production of T3S API, IMP and FDF"
}
}